SEARCH

SEARCH BY CITATION

References

  • 1
    Apstein, MD & Carey, MC. Pathogenesis of cholesterol gallstones: a parsimonious hypothesis. Eur J Clin Invest 1996; 26, 343 52.
  • 2
    Van Erpecum, KJ & VanBerge-Henegouwen, GP. Gallstones: an intestinal disease? Gut 1999; 44, 435 8.
  • 3
    Pomeranz, IS & Shaffer, EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88, 787 91.
  • 4
    Van Erpecum, KJ, VanBerge-Henegouwen, GP, Stolk, MFJ et al. Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. J Hepatol 1992; 14, 194 202.
  • 5
    Chen, Q, Amaral, J, Oh, S, Biancani, P, Behar, J. Gallbladder relaxation in patients with pigment and cholesterol stones. Gastroenterology 1997; 113, 930 7.
  • 6
    Xu, QW & Shaffer, EA. The potential site of impaired gallbladder contractility in an animal model of cholesterol gallstone disease. Gastroenterology 1996; 110, 251 7.
  • 7
    Pauletzki, J, Althaus, R, Holl, J, Sackmann, M, Paumgartner, G. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology 1996; 111, 765 71.
  • 8
    Shoda, J, He, B, Tanaka, N et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo synthesis of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 1995; 21, 1291 1302.
  • 9
    Heaton, KW, Emmett, PM, Symes, CL, Braddon, FEM. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 1993; 341, 8 10.
  • 10
    Hussaini, SH, Pereira, SP, Murphy, GM, Dowling, RH. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile. Hepatology 1995; 22, 1735 44.
  • 11
    Hussaini, SH, Murphy, GM, Kennedy, C et al. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology 1994; 107, 1503 13.
  • 12
    Stolk, MFJ, Van Erpecum, KJ, Smout, AJPM et al. Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying. Am J Physiol 1993; 264, G596 G600.
  • 13
    Stolk, MFJ, Van Erpecum, KJ, Samson, M, Stolk, MFJ, ed. Pathogenesis of Cholesterol Gallstones. Thesis, Utrecht: Universiteit Utrecht: 1993; 65–78.
  • 14
    Xu, QW, Scott, RB, Tan, DTM, Shaffer, EA. Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin. Gut 1998; 43, 817 22.
  • 15
    Xu, QW, Scott, RB, Tan, DT, Shaffer, EA. Effect of prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease. Hepatology 1998; 28, 613 9.
  • 16
    Catnach, SM, Fairclough, PD, Trembath, RC et al. Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology 1992; 102, 2071 6.
  • 17
    Catnach, SM, Ballinger, AB, Stevens, M et al. Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy. Gut 1993; 34, 1123 7.
  • 18
    Luiking, YC, Peeters, TL, Stolk, MFJ et al. Motilin induces gallbladder emptying and antral contractions in the fasted state in humans. Gut 1998; 42, 830 5.
  • 19
    Palasciano, G, Portincasa, P, Belfiore, A, Baldassare, G, Albano, O. Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans. Gastroenterology 1992; 102, 633 9.
  • 20
    Portincasa, P, Di Ciaula, A, Palmieri, V, VanBerge-Henegouwen, GP, Palasciano, G. Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects. Eur J Clin Invest 1995; 25, 746 53.
  • 21
    Van Erpecum, KJ, VanBerge-Henegouwen, GP, Stolk, MFJ et al. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects. Gastroenterology 1990; 99, 836 42.
  • 22
    Festi, D, Frabboni, R, Bazzoli, F et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990; 99, 1779 85.
  • 23
    Van De Heijning, BJM, Van De Meeberg, PC, Portincasa, P et al. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Dig Dis Sci 1999; 44, 190 6.
  • 24
    Chen, Q, Amaral, J, Biancani, P, Behar, J. Excess membrane cholesterol lowers human gallbladder muscle contractility and membrane fluidity. Gastroenterology 1999; 116, 678 85.
  • 25
    Sitzmann, JV, Pitt, HA, Steinborn, PA, Pasha, ZR, Sanders, RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 1990; 170, 25 31.
  • 26
    Kalfarentzos, F, Vagenas, C, Michail, A et al. Gallbladder contraction after administration of intravenous amino acids and long-chain triacylglycerols in humans. Nutrition 1991; 7, 347 9.
  • 27
    Gebhard, RL, Prigge, WF, Ansel, HJ et al. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology 1996; 24, 544 8.
  • 28
    Xu, QW & Shaffer, EA. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease. Gastroenterology 1993; 105, 1184 91.
  • 29
    Kapicioglu, S, Senturk, O, Bambul, N, Ilgun, K. Action of cisapride on gallbladder contraction in patients with diabetes mellitus. Hepato-Gastroenterol 1998; 45, 1410 4.
  • 30
    O'donnell, LJD, Wilson, P, Guest, P et al. Indomethacin and postprandial gallbladder emptying. Lancet 1992; 339, 269 71.
  • 31
    Das, A, Baijal, SS, Saraswat, VA. Effect of aspirin on gallbladder motility in patients with gallstone disease. Dig Dis Sci 1995; 40, 1782 5.
  • 32
    Stolk, MFJ, Van Erpecum, KJ, Koppeschaar, HPF et al. Postprandial gallbladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly. Gut 1993; 34, 808 13.
  • 33
    Stolk, MFJ, Van Erpecum, KJ, Koppeschaar, HPF et al. Effects of long-term octreotide treatment on interdigestive gallbladder emptying, antroduodenal motility and motilin release in acromegaly. Gut 1995; 36, 755 60.
  • 34
    Moschetta, A, Stolk, MFJ, Van Ooteghem, NMA et al. Severe impairment of gallbladder (GB) emptying in acromegalic patients after intramuscular depot administration of the long-acting somatostatin analogue Sandostatin-LAR. Gastroenterology 1999; 116, A23(Abstract).
  • 35
    Luiking, YC, Weusten, BLAM, Portincasa, P et al. Effects of long-term oral l-arginine on esophageal motility and gallbladder dynamics in healthy humans . Am J Physiol 1998; 274, G984 G991.
  • 36
    Luman, W, Ardill, JE, Armstrong, E et al. Nitric oxide and gallbladder motor function. Aliment Pharmacol Ther 1998; 12, 425 32.
  • 37
    Jonderko, K, Nowak, A, Kasicka-Jonderko, A, Sliwinski, Z, Kucio, C. Effect of nifedipine on interdigestive gallbladder Volume and postprandial gallbladder emptying in man. Dig Dis Sci 1991; 36, 1434 40.
  • 38
    Hould, FS, Fried, GM, Fazekas, AG, Tremblay, S, Mersereau, WA. Progesterone receptors regulate gallbladder motility. J Surg Res 1988; 46, 505 12.
  • 39
    Messa, C, Maselli, MA, Cavallini, A et al. Sex steroid hormone receptors and human gallbladder motility in vitro. Digestion 1990; 46, 214 9.
  • 40
    Ryan, JP & Pellecchia, D. Effect of progesterone pretreatment on guinea pig gallbladder motility in vitro. Gastroenterology 1982; 83, 81 3.
  • 41
    Thimister, PW, Hopman, WPM, Van Roermund, RF et al. Inhibition of pancreaticobiliary secretion by loperamide in humans. Hepatology 1997; 26, 256 61.
  • 42
    De Boer, SY, Masclee, AA, Lam, WF et al. Hyperglycemia modulates gallbladder motility and small intestinal transit time in man. Dig Dis Sci 1993; 38, 2228 35.
  • 43
    Hashimoto, T, Poston, GJ, Greeley, Gh Jr, Thompson, JC. Calcitonin gene-related peptide inhibits gallbladder contractility. Surgery 1988; 104, 419 23.